News
Eli Lilly is proving that being second but better can also pay. Zepbound, the American firm’s weight-loss jab, was approved ...
6h
NewsNation on MSNDo Medicare, Medicaid cover weight loss drugs? It dependsMedicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.
Zepbound is the preferred weight loss medicine vs. Wegovy and has consistently beaten the latter in U.S. weekly prescriptions ...
Shares of Eli Lilly (NYSE: LLY) sank after the drugmaker lowered its full-year profit outlook, and a potential headwind to ...
U.S. energy firms seek exemption from Trump to transport LNG on U.S.-built ships. China Airlines orders Boeing passenger and ...
Physicians describe common prior authorization challenges when treating patients for obesity and share strategies to overcome ...
A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...
The Associated Press on MSN6d
Lilly star weight-loss drug Zepbound faces coverage challenge from CVS HealthINDIANAPOLIS — Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss ...
Adding to the pressure is that CVS Health has retained coverage of Zepbound's arch rival Wegovy (semaglutide), sold by Novo Nordisk, after negotiating a price cut with the company, along with Novo ...
Eli Lilly won’t lose its grip on the weight loss market despite recent investor concerns. Meanwhile, Zocdoc releases an ...
Gray, or gray market medications, are nothing new, and GLP-1s — the class of weight loss wonder drug that includes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results